X:TSXTMX Group Ltd. Analysis
Data as of 2026-07-30 - not real-time
CA$51.72
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
TMX Group is trading at CAD 51.72, comfortably above its 20‑day (49.69) and 50‑day (49.65) moving averages and just above the 200‑day SMA (50.37), indicating short‑term momentum while the broader trend remains neutral. Technical signals are supportive: the MACD line sits at 0.70 above its signal (0.37) producing a bullish histogram, and the RSI at 61 % suggests still‑healthy demand despite approaching overbought territory. Volume is on an upward trajectory, reinforcing the price advance. On the fundamentals side, TMX posted a 16.5 % YoY revenue rise to CAD 1.79 bn, with razor‑thin gross margins of 92.7 % and an operating margin of 50 %, translating into a robust profit margin of 29.9 % and free cash flow of CAD 533 m. The forward EPS of CAD 2.68 represents a 40 % upside versus the trailing EPS of CAD 1.91, and the company pays a modest dividend yield of 1.78 % on a 46 % payout ratio, suggesting dividend sustainability. However, the DCF‑derived fair value of CAD 42.9 is well below the current price, and a PE of 27 x outpaces the industry average of 18 x, flagging the stock as overvalued. Recent news highlights a record month of financings on the TSX and TSX‑V, with 31 new issuers, underscoring TMX’s pivotal role in Canadian capital formation and providing a catalyst for revenue growth. Balancing strong cash generation and market‑position advantages against a premium valuation leads to a nuanced outlook: short‑term momentum is intact, medium‑term valuation pressures linger, but long‑term fundamentals remain compelling.
Overall, investors should weigh the bullish technical backdrop and solid earnings profile against the current price premium and modest dividend yield when deciding on positioning.
Overall, investors should weigh the bullish technical backdrop and solid earnings profile against the current price premium and modest dividend yield when deciding on positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD histogram and price above short‑term SMAs
- Increasing trading volume supporting momentum
- RSI nearing overbought levels, suggesting limited upside
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong revenue growth and high operating margins
- Premium valuation relative to peers (PE 27 vs industry 18)
- Sustained dividend payout with comfortable cash flow coverage
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic position in Canadian capital formation and expanding listings
- Low beta and stable cash generation enabling dividend growth
- Long‑term upside potential if valuation compresses toward DCF fair value
Key Metrics & Analysis
Financial Health
Revenue Growth16.50%
Profit Margin29.92%
P/E Ratio27.1
ROE11.92%
ROA0.96%
Debt/Equity42.56
P/B Ratio2.9
Op. Cash FlowCA$753.8M
Free Cash FlowCA$533.0M
Industry P/E18.1
Technical Analysis
TrendNeutral
RSI61.4
SupportCA$46.96
ResistanceCA$52.48
MA 20CA$49.69
MA 50CA$49.65
MA 200CA$50.37
MACDBullish
VolumeIncreasing
Fear & Greed Index90.91
Valuation
Fair ValueCA$42.92
Target PriceCA$64.53
Upside/Downside24.77%
GradeOvervalued
TypeGrowth
Dividend Yield1.78%
Risk Assessment
Beta0.40
Volatility25.61%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.